Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Photoactivated adenylyl cyclase in cortical astrocytes promotes synaptic potentiation and reveals alterations in Huntington's disease

  • Sitjà-Roqueta, Laia
  • Ngum, Neville M.
  • Zherebtsov, Evgenii A.
  • Küçükerden, Melike
  • Givehchi, Maryam
  • Bova, Valentina
  • Delicata, Francis
  • Anaya-Cubero, Elena
  • Santamaría Martínez, Enrique
  • Fernández Irigoyen, Joaquín
  • Conde-Berriozabal, Sara
  • Castañé, Anna
  • Sokolovski, Sergei
  • Rafailov, Edik
  • Rodríguez, Manuel J.
  • Alberch, Jordi
  • Dalkara, Deniz
  • Möglich, Andreas
  • Bykov, Alexander
  • Meglinski, Igor
  • Parri, H. Rheinallt
  • Masana, Mercè
Coordinated neuron-astrocyte interactions are crucial for synaptic plasticity and brain function. Cyclic adenosine monophosphate (cAMP) pathways have a key role in modulating plasticity and are disrupted in neurodegenerative diseases. Yet, the role of astrocytic cAMP remains unclear. We addressed this by expressing the photoactivatable adenylyl cyclase DdPAC in cortical astrocytes, enabling cAMP synthesis under red light stimulation. Using electrophysiological and comprehensive proteomic analyses, we determined its effects in wild-type mice. The modulation of astrocytic cAMP triggered long-term synaptic potentiation and rapidly induced the phosphorylation of proteins involved in synaptic transmission, including PKA. In Huntington's Disease (HD) models, DdPAC activation in cortical astrocytes differentially enhanced brain hemodynamics and induced motor learning, while specifically increasing grooming and impairing coordination in HD mice. Thus, we reveal a mechanism of astrocyte-driven plasticity mediated by cAMP elevation and underscore the alterations in astrocytic cAMP signaling associated with HD., This research is part of the NEUROPA and GlioLight project. The NEUROPA Project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 863214. The GlioLight project has received funding from the European Innovation Council under grant Agreement 101129705. The Aston Institute for Membrane Excellence (AIME) is funded by UKRI’s Research England as part of their Expanding Excellence in England (E3) fund. MK is funded by Horizon Europe Marie Skłodowska-Curie Actions (101104889). This study was supported by grants from the Ministerio de Ciencia y Innovación (Spain) y la Agencia Estatal de Investigación, under projects CNS2023-143999 (MM.), PID2021-124896OA-I00 (M.M.), and no. PID2020-119386RB-I00 (J.A. and M.J.R.); Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades and European Regional Development Fund (ERDF) [CIBERNED, to J.A.], Spain. Also, the project has been supported by María de Maeztu Unit of Excellence (CEX2021-001159), the Institute of Neurosciences of the University of Barcelona, Ministry of Science, Innovation, and Universities, and the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, Catalunya) (2021SGR01086).